ASAP BioPharma Conference
  • About
    • Overview
    • Location & Hotel Booking
    • Rates
  • Programming
    • Agenda
    • Keynote Speakers
    • Speakers
    • Workshops
    • Sessions Info
    • All Sessions
    • 100's - Keynotes
    • 200's - Executive Panels
    • 300's - Master Classes
    • 400's - General Sessions
  • Other Info
    • Membership & Certification
    • Conference Sponsors
  • REGISTER
    • 2022 BioPharma Conference
  • A | S | A | P®

Sessions

100 - Keynotes 200 - Executive Panels 300 - Master Classes 400 - General Sessions

100 - Keynotes

Session 101
Democratizing Patient Care Through Digital and Virtual-First Care Solutions
Session 102
Developing a Partnering Playbook for Rare Disease Innovation
Session 103
What Do Biopharma Alliance Managers Need to Know About Digital Transformation?
Session 105
Beyond Process and Governance: Critical Factors to Consider in Constructing and Managing Alliances

200 - Executive Panels

Session 201
Driving Better Business Decisions Through Strategic Alliance Management Intelligence
Session 202
Target of Choice?: A Biotech Blueprint for Big Pharma Alliance Success

300 - Master Classes

Session 301
Using the Power of Positive Influence to Bridge Differences and Drive Alliance Value
Session 302
Future-Proof Alliance Management for Both Traditional and New Innovative Partnerships
Session 303
Adding Value Through Contract Creation, Implementation, and Management

400 - General Sessions

Session 402
Strive to Thrive: Realizing Value Through the Establishment of an Alliance Management Community of Excellence
Session 403
Leveraging ASAP Best Practices to Build, Optimize, and Maintain an Alliance Management–Centric Organization
Session 404
Investing Now for the Next Generation of Alliance Managers
Session 405
From Alliance Managers to Alliance Teams: Adapting Alliance Management in Mega Collaborations
Session 406
Partnering with Internal Stakeholders to Maximize External Alliances
Session 408
Adding Pieces to the Precision Health Puzzle: Alliance Effectiveness in the World of Digitized Health Data
Session 409
Unique Opportunities and Challenges for Strategic Alliances in the Rapidly Growing Fields of Cell and Gene Therapy
Session 410
Lessons Learned in Creating and Maintaining a Vibrant Drug Discovery Alliance Portfolio
Session 411
Partnering in a Pandemic for a Pandemic